22
Views
0
CrossRef citations to date
0
Altmetric
Review

Surgery for low-grade gliomas: current evidence and controversies

&
Pages 13-19 | Published online: 10 Jan 2014

References

  • Laws ER Jr. Resection of low-grade gliomas. J. Neurosurg. 95, 731–732 (2001).
  • Daumas-Duport C, Scheithauer BW, Kelly PJ. A histologic and cytologic method for the spatial definition of gliomas. Mayo Clin. Proc. 62, 435–449 (1987).
  • Piepmeier J, Christopher S, Spencer D et al. Variations in the natural history and survival of patients with supratentorial low-grade astrocytomas. Neurosurgery 38, 872–878; discussion 878–879 (1996).
  • Piepmeier JM, Christopher S. Low-grade gliomas: introduction and overview. J. Neurooncol. 34, 1–3 (1997).
  • Watanabe K, Tachibana O, Yonekawa Y et al. Role of gemistocytes in astrocytoma progression. Lab. Invest. 76, 277–284 (1997).
  • Burger PC, Rawlings CE, Cox EB et al. Clinicopathologic correlations in the oligodendroglioma. Cancer 59, 1345–1352 (1987).
  • Fortin D, Cairncross GJ, Hammond RR. Oligodendroglioma: an appraisal of recent data pertaining to diagnosis and treatment. Neurosurgery 45, 1279–1291; discussion 1291 (1999).
  • Berger MS, Rostomily RC. Low grade gliomas: functional mapping resection strategies, extent of resection, and outcome. J. Neurooncol. 34, 85–101 (1997).
  • Donahue B, Scott CB, Nelson JS et al. Influence of an oligodendroglial component on the survival of patients with anaplastic astrocytomas: a report of Radiation Therapy Oncology Group 83–02. Int. J. Radiat. Oncol. Biol. Phys. 38, 911–914 (1997).
  • Shaw EG, Scheithauer BW, O’Fallon JR. Supratentorial gliomas: a comparative study by grade and histologic type. J. Neurooncol. 31, 273–278 (1997).
  • van Veelen ML, Avezaat CJ, Kros JM et al. Supratentorial low grade astrocytoma: prognostic factors, dedifferentiation, and the issue of early versus late surgery. J. Neurol. Neurosurg. Psychiatry 64, 581–587 (1998).
  • Scerrati M, Roselli R, Iacoangeli M et al. Prognostic factors in low grade (WHO grade II) gliomas of the cerebral hemispheres: the role of surgery. J. Neurol. Neurosurg. Psychiatry 61, 291–296 (1996).
  • Franzini A, Leocata F, Cajola L et al. Low-grade glial tumors in basal ganglia and thalamus: natural history and biological reappraisal. Neurosurgery 35, 817–820; discussion 820–821 (1994).
  • Lote K, Egeland T, Hager B et al. Survival, prognostic factors, and therapeutic efficacy in low-grade glioma: a retrospective study in 379 patients. J. Clin. Oncol. 15, 3129–3140 (1997).
  • Pignatti F, van den Bent M, Curran D et al. Prognostic factors for survival in adult patients with cerebral low-grade glioma. J. Clin. Oncol. 20, 2076–2084 (2002).
  • Johannesen TB, Langmark F, Lote K. Progress in long-term survival in adult patients with supratentorial low-grade gliomas: a population-based study of 993 patients in whom tumors were diagnosed between 1970 and 1993. J. Neurosurg. 99, 854–862 (2003).
  • Salcman M. The natural history of low grade gliomas. In: Benign Cerebral Glioma, Apuzzo MLJ (Ed). American Association of Neurological Surgeons, Park Ridge, IL, USA, 213–229 (1995).
  • Laws ER Jr, Taylor WF, Clifton MB et al. Neurosurgical management of low-grade astrocytoma of the cerebral hemispheres. J. Neurosurg. 61, 665–673 (1984).
  • Salcman M, Kaplan RS, Ducker TB et al. Effect of age and reoperation on survival in the combined modality treatment of malignant astrocytoma. Neurosurgery 10, 454–463 (1982).
  • Medbery CA III, Straus KL, Steinberg SM et al. Low-grade astrocytomas: treatment results and prognostic variables. Int. J. Radiat. Oncol. Biol. Phys. 15, 837–841 (1988).
  • Piepmeier JM. Observations on the current treatment of low-grade astrocytic tumors of the cerebral hemispheres. J. Neurosurg. 67, 177–181 (1987).
  • Soffietti R, Chio A, Giordana MT et al. Prognostic factors in well-differentiated cerebral astrocytomas in the adult. Neurosurgery 24, 686–692 (1989).
  • Chen TC, Hinton DR, Apuzzo, MLJ. Malignant progression in gliomas. In: Benign Cerebral Glioma. Apuzzo MLJ (Ed.). American Association of Neurological Surgeons, Park Ridge, IL, USA, 181–189 (1995).
  • Karim AB, Maat B, Hatlevoll R et al. A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844. Int. J. Radiat. Oncol. Biol. Phys. 36, 549–556 (1996).
  • Bampoe J, Bernstein M. The role of surgery in low grade gliomas. J. Neurooncol. 42, 259–269 (1999).
  • Karim AB, Afra D, Cornu P et al. Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. Int. J. Radiat. Oncol. Biol. Phys. 52, 316–324 (2002).
  • Shaw E, Arusell R, Scheithauer B et al. Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Co-operative Oncology Group study. J. Clin. Oncol. 20, 2267–2276 (2002).
  • Rajan B, Pickuth D, Ashley S et al. The management of histologically unverified presumed cerebral gliomas with radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 28, 405–413 (1994).
  • Recht LD, Lew R, Smith TW. Suspected low-grade glioma: is deferring treatment safe? Ann. Neurol. 31, 431–436 (1992).
  • Barker FG 2nd, Chang SM, Huhn SL et al. Age and the risk of anaplasia in magnetic resonance-nonenhancing supratentorial cerebral tumors. Cancer 80, 936–941 (1997).
  • Ginsberg LE, Fuller GN, Hashmi M et al. The significance of lack of MR contrast enhancement of supratentorial brain tumors in adults: histopathological evaluation of a series. Surg. Neurol. 49, 436–440 (1998).
  • Macdonald DR. Low-grade gliomas, mixed gliomas, and oligodendrogliomas. Semin. Oncol. 21, 236–248 (1994).
  • Behin A, Hoang-Xuan K, Carpentier AF et al. Primary brain tumours in adults. Lancet 361, 323–331 (2003).
  • McKeever PE, Strawderman MS, Yamini B et al. MIB-1 proliferation index predicts survival among patients with grade II astrocytoma. J. Neuropathol. Exp. Neurol. 57, 931–936 (1998).
  • McGirt MJ, Villavicencio AT, Bulsara KR et al. MRI-guided stereotactic biopsy in the diagnosis of glioma: comparison of biopsy and surgical resection specimen. Surg. Neurol. 59, 277–281; discussion 281–282 (2003).
  • DeAngelis LM. Brain tumors. N. Engl. J. Med. 344, 114–123 (2001).
  • Klein M, Engelberts NH, van der Ploeg HM et al. Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life. Ann. Neurol. 54, 514–520 (2003).
  • Cascino GD. Epilepsy and brain tumors: implications for treatment. Epilepsia 31(Suppl. 3), S37–S44 (1990).
  • Gunnarsson T, Olafsson E, Sighvatsson V et al. Surgical treatment of patients with low-grade astrocytomas and medically intractable seizures. Acta. Neurol. Scand. 105, 289–292 (2002).
  • Berger MS, Ghatan S, Haglund MM et al. Low-grade gliomas associated with intractable epilepsy: seizure outcome utilizing electrocorticography during tumor resection. J. Neurosurg. 79, 62–69 (1993).
  • Jooma R, Yeh HS, Privitera MD et al. Lesionectomy versus electrophysiologically guided resection for temporal lobe tumors manifesting with complex partial seizures. J. Neurosurg. 83, 231–236 (1995).
  • Zentner J, Hufnagel A, Wolf HK et al. Surgical treatment of neoplasms associated with medically intractable epilepsy. Neurosurgery 41, 378–386; discussion 386–387 (1997).
  • Berger MS. Role of surgery in diagnosis and management. In: Benign Cerebral Glioma, Apuzzo MLJ (Ed). American Association of Neurological Surgeons, Park Ridge, IL, USA, 293–307 (1995).
  • Keles GE, Lamborn KR, Berger MS. Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome. J. Neurosurg. 95, 735–745 (2001).
  • Vogelstein B, Kinzler KW. The multistep nature of cancer. Trends Genet. 9, 138–141 (1993).
  • Berger MS, Deliganis AV, Dobbins J et al. The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas. Cancer 74, 1784–1791 (1994).
  • Hall WA, Liu H, Truwit CL. Functional magnetic resonance imaging-guided resection of low-grade gliomas. Surg. Neurol. 64, 20–27; discussion 27 (2005).
  • Roessler K, Donat M, Lanzenberger R et al. Evaluation of preoperative high magnetic field motor functional MRI (3 Tesla) in glioma patients by navigated electrocortical stimulation and postoperative outcome. J. Neurol. Neurosurg. Psychiatry 76, 1152–1157 (2005).
  • Duffau H, Capelle L, Denvil D et al. Usefulness of intraoperative electrical subcortical mapping during surgery for low-grade gliomas located within eloquent brain regions: functional results in a consecutive series of 103 patients. J. Neurosurg. 98, 764–778 (2003).
  • Meyer FB, Bates LM, Goerss SJ et al. Awake craniotomy for aggressive resection of primary gliomas located in eloquent brain. Mayo. Clin. Proc. 76, 677–687 (2001).
  • Danks RA, Aglio LS, Gugino LD et al. Craniotomy under local anesthesia and monitored conscious sedation for the resection of tumors involving eloquent cortex. J. Neurooncol. 49, 131–139 (2000).
  • Vives KP, Piepmeier JM. Complications and expected outcome of glioma surgery. J. Neurooncol. 42, 289–302 (1999).
  • Peraud A, Ilmberger J, Reulen HJ. Surgical resection of gliomas WHO grade II and III located in the opercular region. Acta. Neurochir. 146, 9–17; discussion 17–18 (2004).
  • Haglund MM, Berger MS, Shamseldin M et al. Cortical localization of temporal lobe language sites in patients with gliomas. Neurosurgery 34, 567–576; discussion 576 (1994).
  • Cairncross JG, Laperriere NJ. Low-grade glioma. To treat or not to treat? Arch. Neurol. 46, 1238–1239 (1989).
  • Lunsford LD, Somaza S, Kondziolka D et al. Survival after stereotactic biopsy and irradiation of cerebral nonanaplastic, nonpilocytic astrocytoma. J. Neurosurg. 82, 523–529 (1995).
  • Shaw EG, Scheithauer BW, O’Fallon JR et al. Mixed oligoastrocytomas: a survival and prognostic factor analysis. Neurosurgery 34, 577–582; discussion 582 (1994).
  • Shibamoto Y, Kitakabu Y, Takahashi M et al. Supratentorial low-grade astrocytoma. Correlation of computed tomography findings with effect of radiation therapy and prognostic variables. Cancer 72, 190–195 (1993).
  • Philippon JH, Clemenceau SH, Fauchon FH et al. Supratentorial low-grade astrocytomas in adults. Neurosurgery 32, 554–559 (1993).
  • Leighton C, Fisher B, Bauman G et al. Supratentorial low-grade glioma in adults: an analysis of prognostic factors and timing of radiation. J. Clin. Oncol. 15, 1294–1301 (1997).
  • Gajjar A, Sanford RA, Heideman R et al. Low-grade astrocytoma: a decade of experience at St. Jude Children’s Research Hospital. J. Clin. Oncol. 15, 2792–2799 (1997).
  • Campbell JW, Pollack IF. Cerebellar astrocytomas in children. J. Neurooncol. 28, 223–231 (1996).
  • Balkhoyor KB, Bernstein M. Involution of diencephalic pilocytic astrocytoma after partial resection. Report of two cases in adults. J. Neurosurg. 93, 484–486 (2000).
  • Kawano N. Pleomorphic xanthoastrocytoma: some new observations. Clin. Neuropathol. 11, 323–328 (1992).
  • Kepes JJ. Pleomorphic xanthoastrocytoma: the birth of a diagnosis and a concept. Brain Pathol. 3, 269–274 (1993).
  • Pahapill PA, Ramsay DA, Del Maestro RF. Pleomorphic xanthoastrocytoma: case report and analysis of the literature concerning the efficacy of resection and the significance of necrosis. Neurosurgery 38, 822–828; discussion 828–829 (1996).
  • Shepherd CW, Scheithauer BW, Gomez MR et al. Subependymal giant cell astrocytoma: a clinical, pathological, and flow cytometric study. Neurosurgery 28, 864–868 (1991).
  • Miller DC, Lang FF, Epstein FJ. Central nervous system gangliogliomas. Part 1: pathology. J. Neurosurg. 79, 859–866 (1993).
  • Lang FF, Epstein FJ, Ransohoff J et al. Central nervous system gangliogliomas. Part 2: clinical outcome. J. Neurosurg. 79, 867–873 (1993).
  • Johnson JH Jr, Hariharan S, Berman J et al. Clinical outcome of pediatric gangliogliomas: ninety-nine cases over 20 years. Pediatr. Neurosurg. 27, 203–207 (1997).
  • Daumas-Duport C, Scheithauer BW, Chodkiewicz JP et al. Dysembryoplastic neuroepithelial tumor: a surgically curable tumor of young patients with intractable partial seizures. Report of thirty-nine cases. Neurosurgery 23, 545–556 (1988).
  • Schild SE, Scheithauer BW, Haddock MG et al. Central neurocytomas. Cancer 79, 790–795 (1997).
  • Soylemezoglu F, Scheithauer BW, Esteve J et al. Atypical central neurocytoma. J. Neuropathol. Exp. Neurol. 56, 551–556 (1997).
  • Rades D, Schild SE, Fehlauer F. Prognostic value of the MIB-1 labeling index for central neurocytomas. Neurology 62, 987–989 (2004).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.